NZ239372A - Inhibition of herpes virus infection by antisense oligomers - Google Patents

Inhibition of herpes virus infection by antisense oligomers

Info

Publication number
NZ239372A
NZ239372A NZ239372A NZ23937291A NZ239372A NZ 239372 A NZ239372 A NZ 239372A NZ 239372 A NZ239372 A NZ 239372A NZ 23937291 A NZ23937291 A NZ 23937291A NZ 239372 A NZ239372 A NZ 239372A
Authority
NZ
New Zealand
Prior art keywords
oligomer
gene
virus
use according
target sequence
Prior art date
Application number
NZ239372A
Other languages
English (en)
Inventor
Bernard Riozman
Kameron W Maxwell
Original Assignee
Genta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genta Inc filed Critical Genta Inc
Publication of NZ239372A publication Critical patent/NZ239372A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1133—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against herpetoviridae, e.g. HSV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
    • C12N2310/3521—Methyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NZ239372A 1990-08-15 1991-08-13 Inhibition of herpes virus infection by antisense oligomers NZ239372A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56850190A 1990-08-15 1990-08-15

Publications (1)

Publication Number Publication Date
NZ239372A true NZ239372A (en) 1997-06-24

Family

ID=24271562

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ239372A NZ239372A (en) 1990-08-15 1991-08-13 Inhibition of herpes virus infection by antisense oligomers

Country Status (10)

Country Link
EP (1) EP0547149A4 (fr)
JP (1) JPH06500469A (fr)
KR (1) KR930701105A (fr)
AU (2) AU8617691A (fr)
CA (1) CA2089476A1 (fr)
IE (1) IE912883A1 (fr)
IL (1) IL99172A (fr)
NZ (1) NZ239372A (fr)
TW (1) TW226408B (fr)
WO (1) WO1992003051A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105595A1 (fr) * 1992-09-23 1994-03-24 Ramaswamy Narayanan Polynucleotides antisens
ATE188479T1 (de) 1994-06-01 2000-01-15 Hybridon Inc Verzweigte oligonukleotide als pathogenhemmende mittel
WO1996013608A2 (fr) * 1994-10-28 1996-05-09 Innogenetics N.V. Sequences d'acide polynucleique utilisees dans la detection et la differenciation d'organismes procaryotes
CA2223032A1 (fr) * 1997-02-21 1998-08-21 Smithkline Beecham Corporation Utilisation de ul-15 et de vp5 du hsv-1 pour la detection d'agents antiviraux
KR101360955B1 (ko) 2002-09-13 2014-02-10 레플리코르 인코포레이티드 비서열 상보적 항바이러스 올리고뉴클레오티드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ209840A (en) * 1983-10-17 1988-11-29 Kaji Akira A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
US5248670A (en) * 1990-02-26 1993-09-28 Isis Pharmaceuticals, Inc. Antisense oligonucleotides for inhibiting herpesviruses
CA2092711A1 (fr) * 1990-09-21 1992-03-22 Laure Aurelian Compositions et methodes permettant d'inhiber la croissance ou la replication des virus

Also Published As

Publication number Publication date
WO1992003051A1 (fr) 1992-03-05
KR930701105A (ko) 1993-06-11
AU8617691A (en) 1992-03-17
AU3776395A (en) 1996-02-29
IL99172A (en) 1999-03-12
JPH06500469A (ja) 1994-01-20
EP0547149A1 (fr) 1993-06-23
IE912883A1 (en) 1992-02-26
IL99172A0 (en) 1992-07-15
TW226408B (fr) 1994-07-11
CA2089476A1 (fr) 1992-02-16
EP0547149A4 (en) 1993-09-01

Similar Documents

Publication Publication Date Title
US5789573A (en) Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
JP3482209B2 (ja) オリゴヌクレオチドｎ３’→ｐ５’ホスホルアミデート：合成および化合物；ハイブリダイゼーションおよびヌクレアーゼ耐性特性
US6043352A (en) 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
US5532130A (en) Methods and compositions for sequence-specific hybridization of RNA by 2'-5' oligonucleotides
US6028188A (en) Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
US5596091A (en) Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
AU2003202376A1 (en) Oligonucleotides comprising alternating segments and uses thereof
WO2003064441A2 (fr) Oligonucleotides comportant des segments alternatifs et utilisations associees
JPH03190895A (ja) 修飾ヌクレオチド化合物
NZ277616A (en) Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphate internucleosidyl linkages
CA2285921C (fr) Compositions et procedes pour le traitement des infections par le cytomegalovirus
US5563050A (en) Antisense oligonucleotides against HSV 1, and their preparation
CA2419563C (fr) Antisens chimerique d'analogues de l'arabinofuranose analogue et nucleotides de desoxyribose
NZ239372A (en) Inhibition of herpes virus infection by antisense oligomers
AU698089B2 (en) Oligonucleotides with anti-cytomegalovirus activity
JPH09505307A (ja) 多キラル合成フォスホネートオリゴマー類
EP0656942A1 (fr) Compositions et procedes inhibant la croissance ou la replication de virus
WO1998027425A1 (fr) Purification a grande echelle d'oligonucleotides de longueur totale par extraction par affinite solide-liquide
US20020052331A1 (en) Compositions and methods for antisense inhibition of protein translation
WO1997014708A1 (fr) Oligonucleotides contenant des derives nucleosides a substitution thiol et procedes d'utilisation desdits oligonucleotides
WO1998039353A1 (fr) Vecteurs oligonucleotidiques chimeres ameliores